Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$16.62 - $18.94 $611,250 - $696,575
-36,778 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$15.15 - $19.78 $1.46 Million - $1.9 Million
-96,166 Reduced 72.34%
36,778 $636,000
Q4 2020

Feb 16, 2021

SELL
$16.86 - $19.67 $9.96 Million - $11.6 Million
-590,497 Reduced 81.62%
132,944 $2.52 Million
Q3 2020

Nov 13, 2020

BUY
$15.4 - $20.16 $2.91 Million - $3.81 Million
189,021 Added 35.37%
723,441 $12.6 Million
Q2 2020

Aug 18, 2020

BUY
$18.24 - $21.45 $86,822 - $102,102
4,760 Added 0.9%
534,420 $9.83 Million
Q1 2020

Aug 18, 2020

SELL
$16.28 - $25.63 $1.1 Million - $1.73 Million
-67,360 Reduced 11.28%
529,660 $10.6 Million
Q4 2019

Aug 18, 2020

BUY
$19.57 - $23.52 $11.7 Million - $14 Million
597,020 New
597,020 $13.9 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Gwm Asset Management LTD Portfolio

Follow Gwm Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gwm Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gwm Asset Management LTD with notifications on news.